These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21883724)

  • 1. Total lymphocyte count is a good marker for HIV-related mortality and can be used as a tool for starting HIV treatment in a resource-limited setting.
    Oudenhoven HP; Meijerink H; Wisaksana R; Oetojo S; Indrati A; van der Ven AJ; van Asten HA; Alisjahbana B; van Crevel R
    Trop Med Int Health; 2011 Nov; 16(11):1372-9. PubMed ID: 21883724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
    Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
    Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total lymphocyte count is a reliable surrogate marker for CD4 cell counts after the first year of antiretroviral therapy: data from an Indonesian cohort study.
    de Jong MA; Wisaksana R; Meijerink H; Indrati A; van de Ven AJ; Alisjahbana B; van Crevel R
    Trop Med Int Health; 2012 May; 17(5):581-3. PubMed ID: 22364582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring antiretroviral therapy in HIV/AIDS patients in resource-limited settings: CD4 counts or total lymphocyte counts?
    Mbanya D; Assah F; Ndembi N; Kaptue L
    Int J Infect Dis; 2007 Mar; 11(2):157-60. PubMed ID: 16762583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the efficacy of total lymphocyte counts as predictors of AIDS defining infections in HIV-1 infected people.
    Stebbing J; Sawleshwarkar S; Michailidis C; Jones R; Bower M; Mandalia S; Nelson M; Gazzard B
    Postgrad Med J; 2005 Sep; 81(959):586-8. PubMed ID: 16143689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total lymphocyte count of 1200 is not a sensitive predictor of CD4 lymphocyte count among patients with HIV disease in Kampala, Uganda.
    Kamya MR; Semitala FC; Quinn TC; Ronald A; Njama-Meya D; Mayanja-Kizza H; Katabira ET; Spacek LA
    Afr Health Sci; 2004 Aug; 4(2):94-101. PubMed ID: 15477187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation analysis on total lymphocyte count and CD4 count of HIV-infected patients.
    Liu FR; Guo F; Ye JJ; Xiong CF; Zhou PL; Yin JG; Ye LX
    Int J Clin Pract; 2008 Jun; 62(6):955-60. PubMed ID: 17983435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total lymphocyte count as a surrogate marker to predict CD4 count in human immunodeficiency virus-infected children: a retrospective evaluation.
    Wang Y; Li Y; Wang C; Liang S; Guo J; Li Z; Zhang M; Li W
    Pediatr Infect Dis J; 2012 Jan; 31(1):61-3. PubMed ID: 22217967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4 percentage is an independent predictor of survival in patients starting antiretroviral therapy with absolute CD4 cell counts between 200 and 350 cells/microL.
    Moore DM; Hogg RS; Yip B; Craib K; Wood E; Montaner JS
    HIV Med; 2006 Sep; 7(6):383-8. PubMed ID: 16903983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total lymphocyte count: a surrogate marker for predicting CD4+ count in enrolled process for antiretroviral therapy in resource-limited settings.
    Susaengrat W; Mitchai M; Leerattanapetch N
    J Med Assoc Thai; 2008 Oct; 91(10):1514-7. PubMed ID: 18972893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of immune recovery and the association with late mortality while on antiretroviral treatment in Cambodia.
    van Griensven J; Thai S
    Trans R Soc Trop Med Hyg; 2011 Dec; 105(12):694-703. PubMed ID: 21962614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 subtype E progression among northern Thai couples: traditional and non-traditional predictors of survival.
    Costello C; Nelson KE; Suriyanon V; Sennun S; Tovanabutra S; Heilig CM; Shiboski S; Jamieson DJ; Robison V; Rungruenthanakit K; Duerr A
    Int J Epidemiol; 2005 Jun; 34(3):577-84. PubMed ID: 15737969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting CD4 count using total lymphocyte count: a sustainable tool for clinical decisions during HAART use.
    Mwamburi DM; Ghosh M; Fauntleroy J; Gorbach SL; Wanke CA
    Am J Trop Med Hyg; 2005 Jul; 73(1):58-62. PubMed ID: 16014833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The search for a predictor of CD4 cell count continues: total lymphocyte count is not a substitute for CD4 cell count in the management of HIV-infected individuals in a resource-limited setting.
    Akinola NO; Olasode O; Adediran IA; Onayemi O; Murainah A; Irinoye O; Elujoba AA; Durosinmi MA
    Clin Infect Dis; 2004 Aug; 39(4):579-81. PubMed ID: 15356826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of non-viral load surrogate markers in HIV-positive patient monitoring during antiviral treatment.
    Florence E; Dreezen C; Schrooten W; Van Esbroeck M; Kestens L; Fransen K; De Roo A; Colebunders R
    Int J STD AIDS; 2004 Aug; 15(8):538-42. PubMed ID: 15307965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total lymphocyte count and hemoglobin combined to predict CD4 lymphocyte counts of less than 200 cells/mm(3) in HIV/AIDS.
    Wilhan ; Budiono E
    Acta Med Indones; 2008 Apr; 40(2):59-62. PubMed ID: 19054881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of total lymphocyte count to predict absolute CD4 count in HIV-seropositive cases.
    Gautam H; Saini S; Bhalla P; Singh T
    J Int Assoc Physicians AIDS Care (Chic); 2010; 9(5):292-5. PubMed ID: 20923954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3.
    Lapadula G; Torti C; Maggiolo F; Casari S; Suter F; Minoli L; Pezzoli C; Di Pietro M; Migliorino G; Ouiros-Roldan E; Ladisa N; Sighinolfi L; Costarelli S; Carosi G;
    Antivir Ther; 2007; 12(6):941-7. PubMed ID: 17926648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment initiation with zidovudine-containing potent antiretroviral therapy impairs CD4 cell count recovery but not clinical efficacy.
    Huttner AC; Kaufmann GR; Battegay M; Weber R; Opravil M
    AIDS; 2007 May; 21(8):939-46. PubMed ID: 17457087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy.
    Bisson GP; Gross R; Strom JB; Rollins C; Bellamy S; Weinstein R; Friedman H; Dickinson D; Frank I; Strom BL; Gaolathe T; Ndwapi N
    AIDS; 2006 Aug; 20(12):1613-9. PubMed ID: 16868442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.